Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04055220
Title Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas (REGOSTA)
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Centre Leon Berard
Indications

osteosarcoma

bone sarcoma

Therapies

Regorafenib

Age Groups: adult | child | senior
Covered Countries FRA


No variant requirements are available.